Spideyboy Friday, 02/28/20 02:27:42 AM Re: None Post # of 33564 Funny how everyone loves Geert, then in one day, people start hating on him and so many new posters come out of the cracks to talk trash or nonsense. The situation with the company itself is unchanged (less funds though), so would everyone calm down. If this keeps up though, we're going to need another dilution next month. Last December they raised enough for 1 additional quarter and I mentioned we'd likely need another one, and given the price drop and the Covid-19 turmoil on the markets it is likely difficult to convince warrant holders to convert at the moment. I was expecting the strategy to be to get to results on the last raise, assuming Cel-Sci does have an understanding of the total number of events thus far, otherwise why only raise 1 quarter's worth of cash, but perhaps if ZSBiotech is correct then a new time-point of May 2020 has been put forward. Either-way a new raise pre-results is looking more likely now. I don't see why Cel-Sci doesn't open an ATM. They could take when they want at the higher market prices, especially as they are clearly going to need significantly more cash, pre and/or post-results. However yes we should still take it as good news that the trial is still ongoing. Either the drug is amazing, or there's been a big mess up with type of patient recruitment, but that shouldn't be the case. I don't buy the concern on drop-outs either as the IDMC ought to have mentioned something on that by now.